APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 27 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,263,336 | -61.3% | 2,202,000 | -75.5% | 0.00% | -50.0% |
| Q4 2021 | $13,611,000 | +0.9% | 9,002,000 | -18.2% | 0.00% | 0.0% |
| Q3 2021 | $13,491,000 | -9.7% | 11,002,000 | +35.8% | 0.00% | -20.0% |
| Q2 2021 | $14,938,000 | +31.3% | 8,102,000 | 0.0% | 0.01% | +25.0% |
| Q1 2021 | $11,374,000 | -38.4% | 8,102,000 | -26.4% | 0.00% | -42.9% |
| Q4 2020 | $18,458,000 | +115.9% | 11,002,000 | +37.5% | 0.01% | +133.3% |
| Q3 2020 | $8,550,000 | – | 8,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 15,000,000 | $35,954,355 | 1.42% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $28,207,024 | 0.34% |
| LINDEN ADVISORS LP | 10,000,000 | $23,952,985 | 0.25% |
| Verition Fund Management LLC | 4,796 | $11,487,633 | 0.15% |
| LORD, ABBETT & CO. LLC | 11,712,000 | $28,044 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,267,000 | $3,044,070 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 14,242,000 | $34,113 | 0.04% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $717,076 | 0.01% |
| D. E. Shaw & Co., Inc. | 5,000,000 | $11,995,383 | 0.01% |
| Citadel Advisors | 11,500,000 | $27,556,934 | 0.01% |